Jimmy Bechtel sits down with Jeff Zucker, Chief Development Officer, and Brandon Lenfest, Regional Director at Tekton Research, to dig into what makes CNS and neuroscience trials uniquely challenging for sites. They cover why patient identification in this space requires a completely different approach, the often overlooked but critical role caregivers play, and what sites can do to keep patients engaged through the full length of a study. Jeff and Brandon also get into the balancing act of providing empathetic care while managing placebo response, and share practical advice for sites considering making the move into CNS research for the first time.